Ramos EA, Muiño JM, Diamante M, Echagüe A, Puia SA, Caruso D. Surgery with leukocyte and platelet-rich fibrin (L-PRF) vs. surgery alone for medication-related osteonecrosis of the jaw: A randomized controlled trial. J Clin Exp Dent. 2025;17(7):e756-63.

doi:10.4317/jced.62824

___

References

1. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-43. https://doi.org/10.1016/j.joms.2022.02.008 PMid:35300956

2. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23. https://doi.org/10.1002/jbmr.2405 PMid:25414052

3. Kim J, Lee DH, Dziak R, Ciancio S. Bisphosphonate-related osteonecrosis of the jaw: Current clinical significance and treatment strategy review. Am J Dent. 2020;33(3):115-28. PMid:32470236

4. Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O, Peter JU. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev. 2022;7(7):CD012432. https://doi.org/10.1002/14651858.CD012432.pub3 PMid:35866376 PMCid:PMC9309005

5. Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, et al. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. J Clin Densitom. 2017;20(1):8-24. https://doi.org/10.1016/j.jocd.2016.09.005 PMid:27956123

6. Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G. Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prev Community Dent. 2016;6(2):97-104. https://doi.org/10.4103/2231-0762.178742 PMid:27114946 PMCid:PMC4820581

7. Szentpeteri S, Schmidt L, Restar L, Csaki G, Szabo G, Vaszilko M. The Effect of Platelet-Rich Fibrin Membrane in Surgical Therapy of Medication-Related Osteonecrosis of the Jaw. J Oral Maxillofac Surg. 2020;78(5):738-48. https://doi.org/10.1016/j.joms.2019.12.008 PMid:31945309

8. Muñoz-Salgado A, Silva FF, Padín-Iruegas ME, Camolesi GC, Bernaola-Paredes WE, Veronese HR, et al. Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28(4):e317-29. https://doi.org/10.4317/medoral.25733 PMid:36641740 PMCid:PMC10314351

9. EuroQol [Internet]. 2022 [cited 2024 Oct 27]. EQ-5D-3L. Available from: https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-3l/

10. Park JH, Kim JW, Kim SJ. Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw? J Oral Maxillofac Surg. 2017;75(6):1176-84. https://doi.org/10.1016/j.joms.2016.12.005 PMid:28042979

11. Kim JW, Kim SJ, Kim MR. Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg. 2014;52(9):854-9. https://doi.org/10.1016/j.bjoms.2014.07.256 PMid:25138613

12. Nørholt SE, Hartlev J. Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients. Int J Oral Maxillofac Surg. 2016;45(10):1256-60. https://doi.org/10.1016/j.ijom.2016.04.010 PMid:27179556

13. Zelinka J, Blahak J, Perina V, Pacasova R, Treglerova J, Bulik O. The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165(3):322-7. https://doi.org/10.5507/bp.2020.023 PMid:32597421

14. Özalp Ö, Yıldırımyan N, Öztürk C, Kocabalkan B, Şimşek Kaya G, Sindel A, et al. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin. BMC Oral Health. 2021;21(1):613. https://doi.org/10.1186/s12903-021-01965-7 PMid:34852823 PMCid:PMC8638116

15. Şahin O, Akan E, Tatar B, Ekmekcioğlu C, Ünal N, Odabaşı O. Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients. Braz J Otorhinolaryngol. 2022;88(4):613-20. https://doi.org/10.1016/j.bjorl.2021.04.004 PMid:34023243 PMCid:PMC9422660

16. Valente NA, Chatelain S, Alfonsi F, Mortellaro C, Barone A. Medication-Related Osteonecrosis of the Jaw: The Use of Leukocyte-Platelet-Rich Fibrin as an Adjunct in the Treatment. J Craniofac Surg. 2019;30(4):1095-101. https://doi.org/10.1097/SCS.0000000000005475 PMid:30908443

17. Tenore G, Zimbalatti A, Rocchetti F, Graniero F, Gaglioti D, Mohsen A, et al. Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J Clin Med [Internet]. 2020;9(11):3505. https://doi.org/10.3390/jcm9113505 PMid:33138266 PMCid:PMC7693575

18. Fernando de Almeida Barros Mourão C, Calasans-Maia MD, Del Fabbro M, Le Drapper Vieira F, Coutinho de Mello Machado R, Capella R, et al. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series. J Stomatol Oral Maxillofac Surg. 2020;121(1):84-9. https://doi.org/10.1016/j.jormas.2019.02.011 PMid:30794883

19. Muñoz-Salgado A, Silva FF, Padín-Iruegas ME, Camolesi GC, Bernaola-Paredes WE, Veronese HR, et al. Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023;28(4):e317-29. https://doi.org/10.4317/medoral.25733 PMid:36641740 PMCid:PMC10314351

20. Bensi C, Giovacchini F, Lomurno G, Eramo S, Barraco G, Tullio A. Quality of life in patients affected by medication-related osteonecrosis of the jaws: A systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;132(2):182-9. https://doi.org/10.1016/j.oooo.2021.03.006 PMid:33934955

21. Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, et al. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011;16(1):121-32. https://doi.org/10.1634/theoncologist.2010-0183 PMid:21212433 PMCid:PMC3228058